Introduction Malefyt et al., 1993; Doherty et al., 1993) .
The relatedness of the responses induced by IL-13 The identification of a functional polarization of mouse and IL-4 has been elucidated by studies showing that CD4 ϩ T helper (Th) cell clones based on their cytokine both of these cytokines can interact and cross-compete secretion profiles has provided a molecular insight into for IL-4 receptor ␣ (IL-4R␣) ; Smerzthe regulation of immune responses (Mosmann et al., Bertling and Duschl, 1995) . However, the exact constitu-1986; Mosmann and Coffman, 1989) . Th1 cells secreting tion of the receptor complexes engaging the individual IL-2, interferon-␥ (IFN␥) and lymphotoxin-␤ (LT␤) reprecytokines is poorly understood, though it is apparent sent a T cell subset important in enhancing cellular imthat IL-13 has its own primary binding chains (IL-13R␣1 mune responses, while Th2 cells, characterized by their and IL-13R␣2), to which IL-4 does not bind (Zurawski secretion of IL-4, IL-5, IL-6, IL-9, IL-10, and IL-13, evoke et al., 1995; Aman et al., 1996; Caput et al., 1996; Hilton et al., 1996; Gauchat et al., 1997; Miloux et al., 1997) . Although IL-4 has been reported to interact with IL-2R␥c
shown for IL-13 (He and Malek, 1995; Lin et al., 1995) . Thus, while a number of intracellular signaling pathways are common to IL-13 and IL-4, such as Janus kinase 1 (JAK1) and signal transducer and activator of transcription 6 (Stat6) (Lin et al., 1995) , others may be more specific. Significantly, recent data generated using parasitic nematode infections of IL-4 Ϫ/Ϫ , Stat6 Ϫ/Ϫ , IL-4R␣ Ϫ/Ϫ , and IL-13 Ϫ/Ϫ animals have indicated that IL-13 plays an essential role in Th2 cell-mediated expulsion of these worms McKenzie et al., 1998; Urban et al., 1998) and indicate that in some instances Stat6 signaling is IL-13-dependent. In addition, studies using IL-4 Ϫ/Ϫ and IL-4R␣ Ϫ/Ϫ to study the Th2 cell phenotype induced by Schistosoma mansoni implicate IL-13 in the process of granuloma formation (Jankovic et al., 1998) . Thus, IL-13 plays a critical role in the development of a number of Th2 cell-mediated responses in vivo.
Interestingly, treatment of mice with a polyclonal antibody raised against mIL-13 resulted in a decrease in the levels of IL-4 being made by antigen-specific T cells in response to immunization (Bost et al., 1996) , suggesting that inhibiting IL-13 function results in impaired in their ability to develop a Th2 cell lineage following in vitro Th cell differentiation. We found that antigenspecific responses are less overtly affected by the loss splenocytes was used initially to determine the levels of IL-13 expression and that infection with the Th2-pheof IL-4, IL-5, IL-10, and IFN-␥ being secreted 24-96 hr notype-inducing gastrointestinal nematode Nippostronpoststimulation. Profoundly reduced levels of IL-5 and gylus brasiliensis was able to overcome the impairment.
moderately less IL-4 were produced by cells from the Additionally, IL-13 Ϫ/Ϫ mice have significantly reduced IL-13 Ϫ/Ϫ mice, and IL-5 levels remained low even when IgE levels. These results suggest that IL-13 performs cells were costimulated with excess IL-4 for 96 hr; no a central role in the development of certain immune significant differences were found in IFN␥ production responses and that its interrelatedness with IL-4 is (data not shown). Similar responses were observed with complex.
purified CD4 ϩ T cells stimulated with mitogen (data not shown).
Results
As IL-5 and IL-4 are known to be produced predominantly by Th2 cells, we assessed the consequences of Generation of IL-13-Deficient Mice IL-13 disruption on T helper cell differentiation. Purified Targeted disruption of the mouse IL-13 gene was per-CD4 ϩ T cell cultures were stimulated for 5 days to proformed by inserting the neomycin resistance (neo r ) casmote either Th1 or Th2 differentiation. As expected, resette into exon 3 using a replacement targeting constimulation of cell cultures supporting Th2 differentiation struct ( Figure 1A ). Correctly targeted clones were used from wild-type mice resulted in the secretion of IL-4, to generate chimaeric mice that were bred with 129/J IL-5, and IL-10 ( Figure 2A ). In contrast, equivalent cell mice and transmitted the disrupted allele through the cultures from IL-13 Ϫ/Ϫ mice produced dramatically regermline. Interbreeding of heterozygous (IL-13 ϩ/Ϫ ) mice duced levels of IL-4 and IL-5 and a 2-fold reduction in gave rise to homozygous gene targeted mice (IL-13
IL-10, despite the inclusion of exogenous IL-4 during Figure 1B ). These animals were viable and of normal the 5-day culture period (Figure 2A ). We also noted that appearance and behavior. IL-13-specific ELISA failed Th2 cells from wild-type mice made significant levels of to detect IL-13 protein in supernatants conditioned by IL-13 and that wild-type Th1 cells also produced moderactivated Th2 cells from the IL-13 Ϫ/Ϫ mice ( Figure 2A ).
ate amounts of IL-13. As expected, cells from the ILNo mRNA transcripts encoding IL-13 could be detected 13 Ϫ/Ϫ animals failed to produce IL-13 ( Figure 2A ). Interby RT-PCR using RNA isolated from in vitro culture of estingly, inclusion of IL-13 in the T cell differentiation Concanavalin A (Con A)-stimulated splenocytes from assays failed to reverse the observed phenotype (Figure the IL-13 Ϫ/Ϫ mice, though their wild-type littermates dis-2A). Following T cell restimulation, levels of IFN␥ producplayed normal expression (data not shown).
tion were approximately 2-fold greater from cells derived from IL-13 Ϫ/Ϫ animals compared to levels from wild-type CD4 ؉ T Lymphocytes and Splenocytes Display cells (Figure 2A ).
an Impairment in Th2 Differentiation
To determine whether the inclusion of additional cell We used in vitro assays to assess the result of IL-13 deletion on cytokine production. Con A stimulation of populations into the in vitro Th2 cultures could rescue reverse the impairment in cytokine production from IL-13 Ϫ/Ϫ Th2 cell cultures. The differences in the cytokine profiles were not due to variation in overall cell proliferation, since growth responses to Con A, IL-2, or IL-4 were equivalent in IL-13 Ϫ/Ϫ and wild-type mice (data not shown). Indeed, the up-regulation of activation markers and the proliferation of splenocytes, lymph node cells, and purified T cells in response to IL-4, either alone or in combination with coactivators such as lipopolysaccharide (LPS), anti-IgM, and anti-CD40 were equivalent in both IL-13 Ϫ/Ϫ and wildtype mice (data not shown).
Antigen Stimulation and Parasitic Infection Induce Production of IL-4 and IL-5
We analyzed the CD4 ϩ T cell populations that developed during in vitro differentiation using intracellular cytokine analysis. This demonstrated that populations of IL-4-and IL-5-producing cells were still present but that there was a significant reduction in the number of IL-5-and IL-4-producing cells in the Th2 cell cultures derived from the IL-13-deficient mice, as compared to those from wild-type cultures (data not shown).
The development of cells capable of producing IL-4 and IL-5 was further illustrated when IL-13-deficient mice were challenged with a complex antigen. We assessed the antigen-specific cytokine response generated against schistosome eggs, an antigen that has been shown to induce Th2 cell responses (Pearce et al., served ( Figure 3B ). Thus, the antigen-driven in vivo T cell response was only moderately influenced by the absence of IL-13, in contrast with the profound defect seen in the cell population normally responsive during the observed phenotype, we set up Th2 cultures with total spleen cell populations from IL-13 Ϫ/Ϫ and wildin vitro Th2 cell differentiation. We next assessed the affect of infecting IL-13 Ϫ/Ϫ mice type mice. These total splenocyte assays also failed to overcome the impairment in the in vitro differentiation with the intestinal parasitic nematode N. brasiliensis on the development of Th2 cell populations. Lymph node capacity of Th2 cell lineages in IL-13 Ϫ/Ϫ cell cultures, with significant reductions in IL-4, IL-5, and IL-10 cells were prepared from wild-type and IL-13 Ϫ/Ϫ animals at 6 and 10 days postinfection with N. brasiliensis. These production even in the presence of exogenous . cells were cultured under conditions supporting Th2 cell differentiation, and supernatants were assessed for the The pattern of Th2 cytokine expression remained consistently lower in cells from the IL-13 Ϫ/Ϫ mice irrespecpresence of Th2 cell cytokines. As shown in Figure 3C , the preinfection IL-13 Ϫ/Ϫ lymph node cultures (day 0) tive of whether anti-CD3 or Con A stimulation was used or if cultures included IL-4 or IL-13 (data not shown).
display a significant impairment in IL-4, IL-5, and IL-10 expression, similar to that observed for purified CD4 ϩ IL-13, in the absence of IL-4, also failed to reverse the observed cytokine phenotype in the T cell differentiation T cells and splenocytes using equivalent culture conditions. However, following infection, isolated lymph node assays (data not shown). Furthermore, stimulation of differentiated CD4 ϩ T cells with phorbol myristate acecells from IL-13 Ϫ/Ϫ mice cultured in Th2 cell differentiation conditions now generate typical cytokine responses tate (PMA) and ionomycin, which normally induce significant levels of cytokine expression from T cells, yielded at day 6 postinfection ( Figure 3C ). These results indicate that antigenic challenge in the form of a sustained parasimilar cytokine profiles to those elicited by anti-CD3 and anti-CD28 (data not shown), indicating that a range site infection can overcome the deficit in the signals required to develop Th2 cell responses. of reported cytokine-inducing stimuli were unable to with the IL-13 cDNA probe. The endogenous allele and targeted production by ELISA. Representative data from three repeat experialleles are 6.0 kb and 4.8 kb, respectively. The neomycin excised ments with five animals per group. allele is 3.2 kb (ϩ/Ϫ creed). (B) Mesenteric lymph node cells, isolated from schistosome egg-(C) Mesenteric lymph node cells from wild-type and IL-13 Ϫ/Ϫ creed challenged animals, were cultured using Th2 differentiation condiwere stimulated under Th2 culture conditions for 5 days, washed, tions. Representative data from three repeat experiments with five and restimulated on anti-CD3 antibody-coated plates for 24 hr. Suanimals per group. pernatants were analyzed by ELISA. Data are representative of two (C) Mesenteric lymph node cells were prepared from uninfected repeat experiments with three mice per group. animals (day 0) or animals 6 days and 10 days postinfection with N. brasiliensis. Cells were stimulated under Th2 culture conditions for 5 days, washed, and restimulated on anti-CD3 antibody coated Lymph node cells from these animals and wild-type mice of IL-4 and IL-5 production was still evident in cultures from the IL-13 Ϫ/Ϫ creed mice ( Figure 4C ). These results indicate that even with the removal of the exogenous PGK promoter-driven neomycin gene in vitro Th2 cell Removal of the PGK/Neomycin Resistance Cassette Does Not Reverse the Impairment in In Vitro development is impaired and that promoter interference is not responsible for the observed phenotype.
Th Cell Differentiation
Since it was possible that the impairment in T helper cell responses might be due to the presence of the Mast Cell Cytokine Production Is Unaffected by IL-13 Deletion exogenous phosphoglycerate kinase (PGK) promoter used to drive the expression of the neomycin resistance To determine whether there was a global change in the secretion of IL-4 and IL-5, we isolated mast cell populagene, we utilized cre-mediated loxP recombination to remove both of these elements from targeted ES cells tions from spleen and bone marrow and assessed their ability to produce these cytokines. Significantly, IL-13
( Figures 4A and 4B) . These cells were then used to generate homozygous IL-13 Ϫ/Ϫ mice that no longer conand wild-type mast cells secreted equivalent levels of IL-4 and IL-5 upon stimulation with PMA and ionomycin, tained the neomycin selectable marker or its promoter. with schistosome eggs and IL-13, or denatured IL-13 (con), were natants were sampled after 24 hr. Cytokine levels were analyzed by cultured with soluble egg antigen for 5 days. Representative data ELISA. Representative data from three repeat experiments with cells from two repeat experiments with five animals in each group. Superprepared from three mice.
natants were assayed for cytokine concentration using ELISA. (B) RT-PCR analysis of spleen-derived mast cells stimulated with (B) Mesenteric lymph node cells, derived from N. brasiliensisIgE and specific antigen, PMA, and calcium ionophore A23187.
infected wild-type animals, IL-13 Ϫ/Ϫ animals, or IL-13 Ϫ/Ϫ animals treated with rmIL-13, were stimulated for 24 hr with Con A. Supernatants were analyzed for the presence of IL-5 and IL-4 by ELISA.
indicating that this cell population is unaffected by Data represent triplicate cultures from five animals per group. deletion ( Figure 5A ); wild-type mast cells also secreted significant levels of IL-13 ( Figure 5A ). Furthermore, RT-(data not shown). Thus, animals were coadministered PCR analysis of IL-4 and IL-5 mRNA produced by ILwith rmIL-13 and schistosome eggs followed by two 13 Ϫ/Ϫ and wild-type mast cells, using samples in which further doses of rmIL-13 intraperitoneally over a 10-day competitive PCR was used to determine relative HPRT period. Mice were then sacrificed and mesenteric lymph levels, indicated identical stimulation-specific transcripnode cells isolated and cultured with antigen. Lymph tional activation in the presence of PMA, ionomycin, or node cells derived from IL-13-treated wild-type animals DNP cross-linked anti-DNP IgE monoclonal antibody produced elevated levels of antigen-induced IL-5 when ( Figure 5B ). These data demonstrate that disruption of cultured in the presence of schistosome soluble egg the IL-13 gene does not affect the development of mast antigen ( Figure 6A ). No such increase was observed in cells or their ability to express Th2-like cytokines and cultures from mice inoculated with denatured IL-13. We indicate that the developmental deficit in Th2-like cytowere also unable to show an increase in IL-5 produced kine production is T cell-specific. Furthermore, since by cultures of IL-13 Ϫ/Ϫ cells (data not shown). Furtherthe IL-13 Ϫ/Ϫ mast cell populations are fully responsive more, there was no reproducible change in the levels to a range of stimuli, including PMA and ionomycin, of IL-4 from either set of animals ( Figure 6A ). Thus, adwhich were unable to elicit IL-4 and IL-5 production ministration of IL-13 with antigen can modulate the exfrom the T cell population in IL-13 Ϫ/Ϫ mice, these results pression of IL-5 in vivo. support the finding that insertion of the neomycin gene
In addition to the results using a protein immunization into this locus has not affected the regulation of the IL-4 strategy, we found that in vivo rmIL-13 treatment of ILand IL-5 genes.
13 Ϫ/Ϫ animals infected with N. brasiliensis induced an increase in the levels of IL-4 and IL-5 secreted following Administration of Recombinant IL-13 and Antigen 24 hr Con A stimulation of mesenteric lymph node cells In Vivo Increases Cytokine Production (data not shown) or CD4 ϩ purified T cells relative to Since addition of IL-13 to in vitro cultures from wildlevels from mock treated animals ( Figure 6B ). Thus, in type or IL-13-deficient animals failed to influence Th2 combination with antigenic challenge, administration of differentiation, we attempted to mediate an in vivo effect IL-13 can influence cytokine secretion patterns. on cytokine production using recombinant mouse IL-13 (rmIL-13) to inoculate both IL-13-deficient and wild-type Reduced Serum IgE Levels and Modulated B Cell mice. The administration of rmIL-13 in the absence of Expression of CD23 in the Absence of IL-13 antigen failed to mediate any effect on subsequent in No significant differences were detected in the number or composition of cells from spleen, thymus, lymph vitro Th2 cell differentiation in wild-type or IL-13 Ϫ/Ϫ mice node, and bone marrow from the wild-type and IL-13 Ϫ/Ϫ Discussion mice when we examined the cell surface expression of a panel of immunoregulatory molecules including CD4, IL-13-deficient mice have highlighted an important regu-CD8, CD3⑀, CD69, CD25, sIgM, CD28, CD90.2, Mac-3, latory role for IL-13 in the development of T helper cell CD80, CD86, c-Kit receptor, Gr-1, TER-119, CD54, F4/ responses and have also raised the issue of a direct 80, B220, CD11b, and IL-4R␣ (data not shown). Howrole for IL-13 in the control of IgE production in the ever, we detected significantly reduced levels of CD23 mouse system. Using a number of in vitro and in vivo expression (the low-affinity receptor for IgE) on B220 ϩ based assays, we have shown that deletion of the ILsplenocytes from the IL-13 Ϫ/Ϫ mice relative to those 13 gene results in attenuated development of certain T from the wild-type animals (data not shown). Culture of cell lineages with a consequent reduction of Th2 cell splenocytes from either wild-type or IL13 Ϫ/Ϫ animals, cytokines. These results are consistent with a study in the presence of anti-CD40 antibody, induced similar in which anti-IL-13 polyclonal antibodies were used to levels of CD23 expression on both populations (data not block IL-13 function, resulting in a significant reduction shown), indicating that the intrinsic ability to up-regulate in T cell-derived IL-4 (Bost et al., 1996) , and a recent expression of CD23 was not impaired in the IL-13 Ϫ/Ϫ report in which IL-4R␣ Ϫ/Ϫ mice exhibited a more severe cells. impairment in Th2 development than that observed in Measurement of serum immunoglobulins in nonimmu-IL-4 Ϫ/Ϫ mice (Barner et al., 1998) . The molecular mechanized IL-13 Ϫ/Ϫ mice revealed a 5-to 20-fold decrease nism(s) by which IL-13 mediates its effects are unclear, in total serum IgE levels compared to wild-type animals, and it remains possible that IL-13 may act indirectly while the levels of other immunoglobulin isotypes were or directly on T cell populations. Intracellular cytokine not significantly different ( Figure 7A ). Upon immunizaanalysis indicated that significantly fewer IL-13 Ϫ/Ϫ T cells tion with ovalbumin/alum, increased production of total are producing IL-4 or IL-5 and that this population does serum IgE was detected in both the wild-type and the not expand as is seen in the wild-type cultures. These IL-13-deficient animals, although the levels seen in the data correlate well with the cytokine ELISA data and IL-13 Ϫ/Ϫ mice did not reach those observed in the wildmay suggest that cytokine production on an individual type controls ( Figure 7B ). Total serum levels of IgE were cell basis is comparable between wild-type and IL-13 Ϫ/Ϫ also found to increase in the IL-13 Ϫ/Ϫ mice upon infection mice and that the defect may lie in the generation of with N. brasiliensis ( Figure 7C ). these cells. Since total IgE expression was perturbed in naive ILTo date, the addition of exogenous IL-13 to the in vitro 13 Ϫ/Ϫ mice, their ability to generate a specific antibody differentiation assays has failed to reverse the cytokine response to a protein antigen was assessed. Wild-type secretion profile observed in T cells isolated from ILand IL-13 Ϫ/Ϫ mice were immunized over a 40-day period 13-deficient mice. Thus, commitment or expansion of a with ovalbumin (OVA) complexed to alum, and serum responsive cell type apparently fails to occur in the ILsamples isolated pre-and postimmunization were ana-13-deficient mice and cannot be redirected in culture, lyzed for OVA-specific immunoglobulin isotype content possibly due to changes in receptor expression and/or by ELISA. The total antigen-specific immunoglobulin reintracellular signaling pathways during development or sponse in wild-type and IL-13 Ϫ/Ϫ mice was comparable, upon derivation of these cells. Since exogenous IL-4 as was the OVA-specific IgG1 response ( Figure 7D) . also failed to reverse the phenotype of the cells from However, while IL-13 Ϫ/Ϫ mice generated small but signifthe IL-13 Ϫ/Ϫ mice, our results suggest that IL-13 acts icant concentrations of OVA-specific IgG2b antibodies upstream of IL-4 in this process. The IL-13 Ϫ/Ϫ phenotype and an elevated OVA-specific IgM response, these isotypes were undetectable in wild-type ( Figure 7D) .
contrasts with that observed in IL-4 Ϫ/Ϫ mice in which CD4 ϩ T cells produce reduced levels of IL-5 and ILIt is evident that administration of antigen can overcome at least some of the impairment in cytokine pro-10 but regain wild-type levels of these cytokines when exogenous IL-4 is added to in vitro differentiation assays duction observed in IL-13 Ϫ/Ϫ mice and that concurrent administration of recombinant IL-13 can enhance Th2 (Kopf et al., 1993; A.N.J.M., unpublished data) .
As IL-13 is a potent modulator of macrophage function cytokine expression still further. It is also apparent that infection of IL-13 Ϫ/Ϫ animals with the gastrointestinal (de Waal Malefyt et al., 1993; Doherty et al., 1993; Muchamuel et al., 1997; Nicoletti et al., 1997) , it is possible nematode worm, N. brasiliensis, circumvents the impairment in Th2 bias seen in vitro. It is noteworthy that at that in the absence of IL-13 macrophages fail to regulate correctly their expression of cytokines such as IL-6 or 10 days postinfection, 24 hr Con A stimulation of lymph node cells results in lower levels of IL-4 production by IL-12, which have been reported to promote T cell differentiation (Manetti et al., 1993; Rincó n et al., 1997) . ILthe IL-13 Ϫ/Ϫ cells as compared to wild-type cells , but that in vitro Th2 culture results 12 is a potent inducer of Th1 cell differentiation (Hsieh et al., 1993) and thus deregulated IL-12 production may in a marked increase in IL-4 production by IL-13 Ϫ/Ϫ cells as compared to wild-type cells ( Figure 3C ), probably as influence the subsequent differentiation potential of T cell lineages in the IL-13 Ϫ/Ϫ animals. Indeed, we did a result of the duration and persistence of the nematode infection. It is possible that infection may enhance other observe that activated macrophages from IL-13 Ϫ/Ϫ mice produced elevated levels of IL-12 (G.J.M., unpublished regulatory pathways such as IL-10, thereby suppressing IL-12 and overcoming the deficit in IL-13. Alternatively, data) and that there was slightly enhanced IFN␥ production in Th1 cell cultures from IL-13 Ϫ/Ϫ mice ( Figure 2A) .
pathways including mast cell-and eosinophil-derived IL-4 may result in the development of IL-13-independent This indirect role for IL-13 in regulating macrophage function and thereby modulating T cell development T cell subsets. Athough there is no precedent for the existence of a may also explain why addition of IL-13 to in vitro cultures failed to reverse the observed phenotype and why by locus control region for the IL-13/IL-4/IL-5 gene cluster, it was formally possible that the promoter driving the contrast in vivo treatment of animals with IL-13 was able to influence Th2-like cytokine production (Figures 6A neo r gene had affected the transcription of these cytokine genes. We felt this explanation was unlikely due to and 6B).
However, an alternative explanation involving a direct the cellular specificity of the phenotype with the precise retention of transcriptional control in mast cells, the uneffect of IL-13 on T cells cannot be ruled out. Observations from the human system have indicated that primary affected IL-4-driven IgE response to N. brasiliensis, the lack of effect on the closely linked ‫04ف(‬ kb) interferon human T cells can respond both functionally to IL-13 (Jinquan et al., 1995) and by phosphorylating Stat6 (Curesponse factor gene (IRF1) (data not shown), and because insertion of the neo r gene into the IL-4 gene (Kü hn riel et al., 1997). In addition, it has been shown that upon activation human T cells down-regulate IL-13R␣1 et al., 1991; Kopf et al., 1993) or the IL-5 gene (Kopf et al., 1996) does not mimic the phenotype seen in the ILexpression (Gauchat et al., 1997) , presumably with an attendant loss of IL-13 responsiveness. Thus, isolated 13-deficient mice. However, to rule out the possibility of promoter interference, we used cre-loxP recombinamouse T cells may become insensitive to IL-13 signals in vitro due to down-regulation of receptor subunits, tion to remove the PGK promoter/neo r gene cassette from the targeted IL-13 locus. Significantly, Th2 cytokine possibly in a manner similar to that described for the IFN␥ receptor on Th1 cells (Pernis et al., 1995) . Certainly, production remained impaired even after the removal of this element, supporting the hypothesis that the the observed impairment of cellular commitment is not simply due to a deficiency in cell surface expression of observed phenotype results from an absence of responding cells and not from an indirect transcriptional IL-4R␣ receptor, as identical levels were detected on T cells from wild-type and IL-13 Ϫ/Ϫ mice (data not shown). defect. The IL-13 Ϫ/Ϫ mice display significantly reduced levels However, IL-13 may be involved in the expression or activation of components of the IL-4/IL-13 signaling of IgE and CD23, and this may be directly attributable to the lack of IL-13 or may also be explained by a failure pathway such as IRS-2, Jak1, Jak3, or Stat6. It is clear that IL-13 and IL-4 share at least a subset of intracellular of the IL-13-deficient T cells to provide sufficient helper functions to generate a robust IgE response. While it is signaling pathways, including the localization of Stat6 to the nucleus (Lin et al., 1995) , and recent studies using clear that IL-4 Ϫ/Ϫ mice have profoundly reduced IgE levels (Kü hn et al., 1991; Kopf et al., 1993) and lower Stat6 Ϫ/Ϫ mice have identified a severe Th2 block (Shimoda et al., 1996; Takeda et al., 1996) possibly due CD23 expression (Hjulströ m et al., 1995) , the attendant reduction in Th2 cytokines including IL-13 may contribto the combined effect of interrupting the downstream signaling pathways of both IL-4 and IL-13 (Kaplan et al., ute to this phenotype. Interestingly, recent studies have shown that IL-4 Ϫ/Ϫ mice can still switch to IgE secretion 1996). The presence of Stat6 binding sites in the IL-4 promoter (Lederer et al., 1996) and IL-4R␣ promoter after infection with Plasmodium chabaudi (Van der Weld et al., 1994) or during the course of a murine acquired (Kotanides and Reich, 1996) presents the possibility that IL-13-induced Stat6 could play a role in modulating IL-4 immunodeficiency syndrome (Morawetz et al., 1996) , thus indicating an IL-4-independent mechanism for the and IL-4R␣ expression, thereby influencing T cell expansion. If this were the case, IL-13 produced by naive T production of IgE. Furthermore, recent data generated in our laboratory have identified IL-13-specific, IL-4-cells (van der Pouw Kraan et al., 1996) may represent an early source of cytokine for eliciting T cell function, independent, IgE regulation in mice transgenic for IL-13 expression (Emson et al., 1998) . Unlike IL-4 Ϫ/Ϫ mice, including the induction of the IL-4 responsible for promoting Th2 cell development.
which display impaired IgG1 responses (Kü hn et al.,
Ovalbumin Immunization
1991; Kopf et al., 1993) , these were normal in the ILMice (8-to 10-week-old) were immunized in the peritoneal cavity 13 Ϫ/Ϫ animals. However, there were enhanced levels of with 100 g of ovalbumin adsorbed to aluminium hydroxide (alum) antigen-specific IgG2a and IgG2b produced by the ILwith subsequent boost injections with 100 g of ovalbumin after 7
13 Ϫ/Ϫ animals, indicative of a more biased Th1 type and 14 days. Alternatively, 8-to 10-week-old mice were immunized phenotype, correlating with slightly enhanced IFN␥ exintraperitoneally with 100 g of ovalbumin/alum with subsequent boost injections with 100 g of ovalbumin/alum after 10, 20, and 30 pression.
days. Serum samples were assayed for immunoglobulin isotypes. Kopf et al. (1993) suggested that IL-4-independent Th subsets may be responsible for the residual Th2 Germany) followed by magnetic field separation to remove MHC Three independently derived IL-13-deficient mouse lines have been class II-, CD8-, and B220-expressing cells. Cell purity was deterused in this study. IL-13KO was generated as follows. Genomic mined using FITC-labeled anti-CD4 and PE-labeled anti-CD8 anti-DNA clones were isolated as detailed in McKenzie et al. (1993b) .
bodies and was generally 90%-95% CD4 ϩ cells. Purified cells were The neomycin resistance gene was inserted into exon 3, with stop cultured on anti-CD3⑀ antibody-coated plates (10 g/ml of clone codons in all three frames 5Ј of the selectable marker. The vector 2C11, Pharmingen) plus anti-CD28 antibody (1 g/ml of clone 37.51, was linearized with SalI and transfected into E14.1 ES cells by elecPharmingen) in the presence of exogenous cytokines or anti-cytotroporation. BglII-digested genomic DNAs from isolated clones were kine antibody as indicated. IL-2 (10 ng/ml, R & D) was added to all screened using a 3Ј flanking probe. The probe was made by PCR cultures. Th2 cell differentiation was promoted in the presence of using the primers 5Ј-AAGAGCCCGAGGCATGATGCG-3Ј and 5Ј-TCT 100 ng/ml IL-4 (R & D) and anti-IFN␥ antibody (10 g/ml of clone GGGCGCTATTGCTTGGTCTCTTCTGCC-3Ј. Subsequent hybridiza-XMG1.2, Pharmingen), while Th1 differentiation was promoted by tion of Southern blots with a neo r probe (probe B) confirmed the anti-IL-4 antibody at 40 g/ml (clone 11B11, DNAX Research Instipredicted size of the targeted fragment and a single integration tute) and IL-12 (1 ng/ml, Genzyme, West Malling, UK). Cells were event. IL-13 Ϫ/Ϫ was generated as described in McKenzie et al. (1998) . cultured for 5 days, washed, and resuspended at 1 ϫ 10 6 cells/ml IL-13 Ϫ/Ϫ creed was generated essentially as outlined in McKenzie for 24 hr in the presence of anti-CD3. Supernatants were analyzed et al. (1998) , with the exception that the neomycin resistance gene by cytokine ELISA performed as above. was excised using cre-mediated loxP recombination. A correctly targeted ES cell clone was identified and transiently transfected N. brasiliensis Infection with plasmid pPGKcrebpA encoding the cre recombinase gene (a Individual mice were inoculated subcutaneously with 400 viable gift from Dr. Werner Muller, Cologne). BamHI-digested genomic third-stage N. brasiliensis larvae. DNAs from isolated ES cell colonies were screened for cre-mediated recombination using Southern analysis employing the mIL-13 cDNA as a probe. Prospective clones were then replica-plated in the presAntigen-Specific T Cell Stimulation Using Soluble ence and absence of G418, and drug-susceptible clones were subSchistosome Egg Antigen cloned and rescreened using Southern analysis. ES cells containing Mice were immunized intraperitoneally with 10,000 nonviable Schisthe correctly recombined targeting event were used to derive chimetosoma mansoni eggs (Pearce et al., 1991) . After 10 days, mesenteric ric mice that were crossed with C57BL/6 females to generate hetero-LN cells were prepared and cultured at 5 ϫ 10 6 cells per ml in the zygous IL-13 ϩ/Ϫ creed animals. These were interbred to generate presence of soluble egg antigen (SEA, 20 g/ml) for 5 days (Pearce homozygous IL-13 Ϫ/Ϫ creed mice and wild-type littermates. . Anti-IL-4R␣ antibody (Genzyme) at 0.5 g/ml was added the exception of the mast cell data, which were only generated for the final 24 hr of culture. Supernatants were analyzed for cytousing the IL-13KO line, all presented experiments were reproduced kines using ELISA. using the IL-13 Ϫ/Ϫ line described in McKenzie et al. (1998) .
Mast Cell Preparation and Stimulation
Bone marrow was aseptically flushed from femora and tibias of RNA Preparation Spleen cells were cultured with 2 g/ml of Con A for 48 hr. Total 8-week-old mice. The cell suspension was cultured at 4 ϫ 10 5 cells/ml in the presence of 5 ng/ml of IL-3 and 10% WEHI-3B condi-RNA was prepared using RNAzolB (Biotecx, Biogenesis, Poole, UK), and polyAϩ RNA was isolated with Oligotex (Qiagen, Dorking, UK). tioned supernatant for 3-4 weeks, with media changes every 7 days. The resultant cell populations were 95% c-kit ϩ and Gr-1 ϩ when RT-PCR primers for IL-13 were 5Ј-GGGTGACTGCAGTCCTGGCT-3Ј and 5Ј-GCTGGAGACCGTAGTGGG-3Ј. The internal oligonucleotide analyzed by flow cytometry (Pharmingen). After washing, cells were resuspended at 1 ϫ 10 6 cells/ml and stimulated either for 4 hr for used for hybridization was 5Ј-CTGTGCAACGGCAGCATGGTA-3Ј. HPRT primers and conditions were as described in Murphy et al.
the analysis of cytokine mRNA production or 24 hr for the determination of secreted cytokine. Cells were stimulated with the polyclonal (1993).
